mesowatch
phone-image
mesowatch
mobile-icon
Targeted phototherapy study Shows low-risk and effective
divider

Targeted phototherapy Shows low-risk and effective for Pleural Mesothelioma

Targeted phototherapy Shows low-risk and effective for Pleural Mesothelioma

Jean Brannum

Reading Time: 3 mins

Published On: August 3, 2020

Jean Brannum - author

Jean Brannum is a science writer who enjoys researching and discussing disease and cancer treatments. She recently graduated from NC State with a degree in biology and a focus in science journalism.

More to Read

divider

September 23, 2024

Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds

divider

September 20, 2024

J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement

divider

September 18, 2024

$39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc

divider

September 11, 2024

Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase

divider

September 10, 2024

J&J Raises Talcum Powder Settlement by Another $1.1 Billion

divider

August 28, 2024

FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma

divider

News & Data

Section divider

FILTER:

Search
Bottom divider

Browse Categories

divider
mesowatch

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy Policy

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
The content on this website is protected by law and provided for informational purposes only. It is not intended as a substitute for professional medical or legal advice. Always seek advice from qualified professionals for health or legal matters.Disclaimer